Castle Biosciences CSTL Net gains (losses) on investments
Net gains (losses) on investments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiGainLoss.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Castle Biosciences's net gains (losses) on investments?
- Castle Biosciences (CSTL) reported net gains (losses) on investments of $2.02M in Q1 2026.
- How has Castle Biosciences's net gains (losses) on investments changed year-over-year?
- Castle Biosciences's net gains (losses) on investments increased by 241.9% year-over-year, from -$1.43M to $2.02M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.